USC Subchapter XXII

in effect

42 U.S.C. § 300dd–21 Demonstration projects

(a) DefinitionsAs used in this section:(1) The term “individuals infected with the etiologic agent for acquired immune deficiency syndrome” means individuals who have a disease, or are recovering from a disease, attributable to the infection of such individuals with such etiologic agent, and as a result of the effects of such disease, are in need of subacute-care services. (2) The term “subacute care” means medical and health care services that are required for individuals recovering from acute care episodes that are less intensive than the level of care provided in acute-care hospitals, and includes skilled nursing care, hospice care, and other types of health services provided in other long-term-care facilities. (b) Authorization to conduct three projectsThe Secretary shall conduct three demonstration projects to determine the effectiveness and cost of providing the subacute-care services described in subsection (b) to individuals infected with the etiologic agent for acquired immune deficiency syndrome, and the impact of such services on the health status of such individuals. (c) Services(1) The services provided under each demonstration project shall be designed to meet the specific needs of individuals infected with the etiologic agent for acquired immune deficiency syndrome, and shall include—(A) the care and treatment of such individuals by providing—(i) subacute care; (ii) emergency medical care and specialized diagnostic and therapeutic services as needed and where appropriate, either directly or through affiliation with a hospital that has experience in treating individuals with acquired immune deficiency syndrome; and (iii) case management services to ensure, through existing services and programs whenever possible, appropriate discharge planning for such individuals; and (B) technical assistance, to other facilities in the region served by such facility, that is directed toward education and training of physicians, nurses, and other health-care professionals in the subacute care and treatment of individuals infected with the etiologic agent for acquired immune deficiency syndrome. (2) Services provided under each demonstration project may also include—(A) hospice services; (B) outpatient care; and (C) outreach activities in the surrounding community to hospitals and other health-care facilities that serve individuals infected with the etiologic agent for acquired immune deficiency syndrome. (d) Time and placeThe demonstration projects shall be conducted—(1) during a 4-year period beginning not later than 9 months after November 4, 1988; and (2) at sites that—(A) are geographically diverse and located in areas that are appropriate for the provision of the required and authorized services; and (B) have the highest incidence of cases of acquired immune deficiency syndrome and the greatest need for subacute-care services. (e) Evaluation and reportThe Secretary shall evaluate the operations of the demonstration projects and shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Labor and Human Resources of the Senate—(1) not later than 18 months after the beginning of the first project, a preliminary report that contains—(A) a description of the sites at which the projects are being conducted and of the services being provided in each project; and (B) a preliminary evaluation of the experience of the projects in the first 12 months of operation; and (2) not later than 6 months after the completion of the last project, a final report that contains—(A) an assessment of the costs of subacute care for individuals infected with the etiologic agent for acquired immune deficiency syndrome, including a breakdown of all other sources of funding for the care provided to cover subacute care; and (B) recommendations for appropriate legislative changes. (f) Other researchEach demonstration project shall provide for other research to be carried out at the site of such demonstration project including—(1) clinical research on acquired immune deficiency syndrome, concentrating on research on the neurological manifestations resulting from infection with the etiologic agent for such syndrome; and (2) the study of the psychological and mental health issues related to such syndrome. (g) Authorization of appropriations(1) To carry out this section, there are authorized to be appropriated $10,000,000 for fiscal year 1989 and such sums as are necessary for each of the fiscal years 1990 through 1992. (2) Amounts appropriated pursuant to paragraph (1) shall remain available until September 10, 1992. (h) Services to veteransThe Secretary shall enter into an agreement with the Secretary of the Department of Veterans Affairs to ensure that appropriate provision will be made for the furnishing, through demonstration projects, of services to eligible veterans, under contract with the Department of Veterans Affairs pursuant to section 1720 of title 38.

42 U.S.C. § 300dd–31 Grants for anonymous testing

The Secretary may make grants to the States for the purpose of providing opportunities for individuals— (1) to undergo counseling and testing with respect to the etiologic agent for acquired immune deficiency syndrome without being required to provide any information relating to the identity of the individuals; and (2) to undergo such counseling and testing through the use of a pseudonym.

42 U.S.C. § 300dd–32 Requirement of provision of certain counseling services

(a) Counseling before testingThe Secretary may not make a grant under section 300dd–31 of this title to a State unless the State agrees that, before testing an individual pursuant to such section, the State will provide to the individual appropriate counseling with respect to acquired immune deficiency syndrome (based on the most recent scientific data relating to such syndrome), including—(1) measures for the prevention of exposure to, and the transmission of, the etiologic agent for such syndrome; (2) the accuracy and reliability of the results of such testing; (3) the significance of the results of such testing, including the potential for developing acquired immune deficiency syndrome; and (4) encouraging individuals, as appropriate, to undergo testing for such etiologic agent and providing information on the benefits of such testing. (b) Counseling of individuals with negative test resultsThe Secretary may not make a grant under section 300dd–31 of this title to a State unless the State agrees that, if the results of testing conducted pursuant to such section indicate that an individual is not infected with the etiologic agent for acquired immune deficiency syndrome, the State will review for the individual the information provided pursuant to subsection (a) with respect to such syndrome, including—(1) the information described in paragraphs (1) through (3) of such subsection; and (2) the appropriateness of further counseling, testing, and education of the individual with respect to acquired immune deficiency syndrome. (c) Counseling of individuals with positive test resultsThe Secretary may not make a grant under section 300dd–31 of this title to a State unless the State agrees that, if the results of testing conducted pursuant to such section indicate that an individual is infected with the etiologic agent for acquired immune deficiency syndrome, the State will provide to the individual appropriate counseling with respect to such syndrome, including—(1) reviewing the information described in paragraphs (1) through (3) of subsection (a); (2) reviewing the appropriateness of further counseling, testing, and education of the individual with respect to acquired immune deficiency syndrome; (3) the importance of not exposing others to the etiologic agent for acquired immune deficiency syndrome; (4) the availability in the geographic area of any appropriate services with respect to health care, including mental health care and social and support services; (5) the benefits of locating and counseling any individual by whom the infected individual may have been exposed to the etiologic agent for acquired immune deficiency syndrome and any individual whom the infected individual may have exposed to such etiologic agent; and (6) the availability, if any, of the services of public health authorities with respect to locating and counseling any individual described in paragraph (5). (d) Rule of construction with respect to counseling without testingAgreements entered into pursuant to subsections (a) through (c) may not be construed to prohibit any grantee under section 300dd–31 of this title from expending the grant for the purpose of providing counseling services described in such subsections to an individual who will not undergo testing described in such section as a result of the grantee or the individual determining that such testing of the individual is not appropriate. (e) Use of funds(1) The purpose of this subpart 11 So in original. Probably should be “part”. is to provide for counseling and testing services to prevent and reduce exposure to, and transmission of, the etiologic agent for acquired immune deficiency syndrome. (2) All individuals receiving counseling pursuant to this subpart 1 are to be counseled about the harmful effects of promiscuous sexual activity and intravenous substance abuse, and the benefits of abstaining from such activities. (3) None of the fund appropriated to carry out this subpart 1 may be used to provide counseling that is designed to promote or encourage, directly, homosexual or heterosexual sexual activity or intravenous drug abuse. (4) Paragraph (3) may not be construed to prohibit a counselor who has already performed the counseling of an individual required by paragraph (2), to provide accurate information about means to reduce an individual’s risk of exposure to, or the transmission of, the etiologic agent for acquired immune deficiency syndrome, provided that any informational materials used are not obscene.

42 U.S.C. § 300dd–33 Funding

For the purpose of grants under section 300dd–31 of this title, there are authorized to be appropriated $100,000,000 for each of the fiscal years 1989 and 1990.